This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyazaki, S
Right arrow Articles by Goto, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyazaki, S
Right arrow Articles by Goto, S

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1991 August; 35(8): 1691-1694

In vitro antibacterial activity of ME1207, a new oral cephalosporin.

S Miyazaki, Y Miyazaki, A Tsuji, M Nishida and S Goto

Department of Microbiology, Toho University School of Medicine, Tokyo, Japan.

ABSTRACT

ME1207 is the prodrug of ME1206. Its in vitro antibacterial activity was compared with that of cefteram, cefpodoxime, cefixime, and cefaclor against various clinical isolates. ME1206 was more active than the other cephems tested against staphylococci, streptococci, Morganella morganii, Pseudomonas cepacia, and Flavobacterium meningosepticum and had the most potent activity against Haemophilus influenzae and Neiserria gonorrhoeae. The drug also showed a wide spectrum of activity against other gram-positive and gram-negative bacteria, except methicillin-resistant Staphylococcus aureus, Enterococcus faecalis, Citrobacter freundii, Pseudomonas aeruginosa, Xanthomonas maltophilia, and Alcaligenes xylosoxydans.


Antimicrob Agents Chemother. 1991 August; 35(8): 1691-1694




This article has been cited by other articles:

  • Clark, C. L., Nagai, K., Dewasse, B. E., Pankuch, G. A., Ednie, L. M., Jacobs, M. R., Appelbaum, P. C. (2002). Activity of cefditoren against respiratory pathogens. J Antimicrob Chemother 50: 33-41 [Abstract] [Full Text]  
  • Kelly, L. M., Jacobs, M. R., Appelbaum, P. C. (1999). Comparison of Agar Dilution, Microdilution, E-Test, and Disk Diffusion Methods for Testing Activity of Cefditoren against Streptococcus pneumoniae. J. Clin. Microbiol. 37: 3296-3299 [Abstract] [Full Text]  
  • Paker, G. E., Graham, J. A., Rauch, A. M., Collins, J. J. (1994). Cefuroxime Axetil in the Treatment of Sinusitis: A Review. Arch Fam Med 3: 165-175 [Abstract]